
Marijuana use doubles risk of dying from heart disease, large study finds
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Using marijuana doubles the risk of dying from heart disease, according to a new analysis of pooled medical data involving 200 million people mostly between the ages of 19 and 59.
'What was particularly striking was that the concerned patients hospitalized for these disorders were young (and thus, not likely to have their clinical features due to tobacco smoking) and with no history of cardiovascular disorder or cardiovascular risk factors,' said senior author Émilie Jouanjus, an associate professor of pharmacology at the University of Toulouse, France, in an email.
Compared to nonusers, those who used cannabis also had a 29% higher risk for heart attacks and a 20% higher risk for stroke, according to the study published Tuesday in the journal Heart.
'This is one of the largest studies to date on the connection between marijuana and heart disease, and it raises serious questions about the assumption that cannabis imposes little cardiovascular risk,' said pediatrician Dr. Lynn Silver, a clinical professor of epidemiology and biostatistics at University of California, San Francisco.
'Getting this right is critically important because cardiovascular disease is the top cause of death both in the United States and globally,' said Silver, who is also senior adviser at the Public Health Institute, a nonprofit public health organization that analyzes marijuana policy and legalization.
Silver is the coauthor of an editorial published with the paper that calls for change in how cannabis is viewed by health professionals, regulatory bodies and the public at large.
'Clinicians need to screen people for cannabis use and educate them about its harms, the same way we do for tobacco, because in some population groups it's being used more widely than tobacco,' she said. 'Our regulatory system, which has been almost entirely focused on creating legal infrastructure and licensing legal, for-profit (cannabis) businesses, needs to focus much more strongly on health warnings that educate people about the real risks.'
The new systematic review and meta-analysis analyzed medical information from large, observational studies conducted in Australia, Egypt, Canada, France, Sweden and the US between 2016 and 2023.
Those studies did not ask people how they used cannabis — such as via smoking, vaping, dabbing, edibles, tinctures or topicals. (Dabbing involves vaporizing concentrated cannabis and inhaling the vapor.) However, 'based on epidemiological data, it is likely that cannabis was smoked in the vast majority of cases,' Jouanjus said.
Smoking tobacco is a well-known cause of heart disease — both the smoke and the chemicals in tobacco damage blood vessels and increase clotting, according to the US Centers for Disease Control and Prevention.
Therefore, it is not surprising that smoking, vaping or dabbing cannabis could do the same, Silver said: 'Any of the many ways of inhaling cannabis are going to have risks to the user, and there's also secondhand smoke risks, which are similar to tobacco.'
The notion that smoking cannabis is less harmful because it's 'natural' is just wrong, Dr. Beth Cohen, professor of medicine at the University of California, San Francisco, told CNN in a prior interview.
'When you burn something, whether it is tobacco or cannabis, it creates toxic compounds, carcinogens, and particulate matter that are harmful to health,' Cohen said in an email.
However, edibles may also play a role in heart disease, according to a May 2025 study.
People who consumed edibles laced with tetrahydrocannabinol, or THC, showed signs of early cardiovascular disease similar to tobacco smokers.
'We found that vascular function was reduced by 42% in marijuana smokers and by 56% in THC-edible users compared to nonusers,' Dr. Leila Mohammadi, an assistant researcher in cardiology at the University of California, San Francisco, told CNN in a prior interview.
None of the studies included in the new meta-analysis asked users about the potency of THC in the products they consume. Even if they had, that information would be quickly outdated, Silver said.
'The cannabis market is a moving target. It is getting more potent every day,' she said.
'What's being sold to people today in California is 510 times stronger than what it was in the 1970s. Concentrates can be 99% pure THC. Vapes are over 80% THC.
'A variety of chemically extracted cannabinoids can be almost pure THC, and all of these just have very different effects on people than smoking a joint in the 1970s.'
Higher potency weed is contributing to a host of problems, including an increase in addiction — a July 2022 study found consuming high-potency weed was linked to a fourfold increased risk of dependence.
In the United States, about 3 in 10 people who use marijuana have cannabis use disorder, the medical term for marijuana addiction, according to the CDC.
'We know that more potent cannabis makes people more likely to become addicted,' Silver said. 'We know that more potent cannabis makes people more likely to develop psychosis, seeing and hearing things that aren't there, or schizophrenia. Habitual users may also suffer from uncontrollable vomiting.'
The rise in potency is one reason that the current study may not have captured the full extent of the risk of marijuana for heart disease, Jouanjus said: 'We are afraid that the association might be even stronger than that reported.'
While science continues to study the risk, experts say it's time to think twice about the potential harms of cannabis use — especially if heart disease is a concern.
'If I was a 60-year-old person who had some heart disease risk, I would be very cautious about using cannabis,' Silver said. 'I've seen older people who are using cannabis for pain or for sleep, some of whom have significant cardiovascular risk, or who have had strokes or had heart attacks or had angina, and they have no awareness that this may be putting them at greater risk.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Sleep Experts Just Shared The Morning Habit You Should Avoid In Order To Get Better Sleep, And I'm Feeling Very Called Out
You've likely heard that a good night of sleep starts in the morning, and sleep experts agree with this statement wholeheartedly. This is because of our circadian rhythm, or our body's natural sleep-wake cycle, which is a 24-hour process. 'The circadian rhythm, your internal biological clock, operates on a roughly 24-hour cycle and dictates when you feel awake or sleepy, largely influenced by light exposure,' explained Dr. Chester Wu, a double-board certified psychiatrist and sleep medicine specialist. 'Health behaviors in the morning reinforce a strong circadian rhythm, promoting wakefulness during the day and sleepiness at night.' Conversely, according to Wu, irregular sleep patterns, excessive evening light exposure and sedentary lifestyles can disrupt this rhythm and sleep pressure balance, leading to sleep issues. Considering they've dedicated their careers to helping people sleep better, it's safe to say the morning routines of sleep doctors are ones we want to emulate. So, what do sleep experts avoid doing in the morning to ensure they get a good night's sleep? They never lie in bed after their alarms go off. Related: "People Don't Understand How Dangerous It Can Be" — 19 Seemingly Safe But Actually Dangerous Things People Do All The Time Staying in bed after your alarm goes off can be doing more harm than good. Related: Boyfriends Are Sharing What They Never Knew About Women Until They Started Dating One, And These Discoveries Are Pure Relationship Gold In what may be the most unrelatable (but definitely smart) action ever, sleep doctors don't lie in bed, scrolling on their phones for 15 minutes before dragging themselves out of bed. 'I try not to linger in bed because I definitely feel like that causes me to feel more lazy or groggy,' Wu said. Chelsie Rohrscheib, a neuroscientist and sleep expert, also doesn't do this. 'I never stay in bed and do activities that aren't related to sleep and intimacy. This means when I wake up, I get out of bed immediately and go somewhere else in my house,' she said. 'This helps to maintain my brain's association that the bedroom is only a place of rest, which promotes high-quality sleep.' 'I never remain in my dark bedroom,' added Dr. Chris Winter, a neurologist and sleep health expert. 'It is essential to get into the light. Light effectively shuts off your brain's production of melatonin and lets your body know the day has begun.' While not lying in bed was the most popular tip among the sleep experts we consulted, Carleara Weiss, a sleep specialist and research assistant professor at the University at Buffalo, State University of New York, gave a slightly different answer: For her, in addition to getting up as soon as she wakes up, she makes sure not to sleep in. 'The reasoning for that relates to the circadian rhythms,' Weiss said. 'Regular wake-up times help the biological clock regulate physiological functions, not just sleep. Sleeping in on the weekends leads to social jet lag and causes difficulty concentrating, fatigue, irritability, and headaches.' Dr. Raj Dasgupta ― a physician who is a quadruple board-certified physician in internal medicine, pulmonary, critical care and sleep medicine ― is also wary of sleeping in. 'While occasionally sleeping in is unlikely to have a lasting impact on your overall sleep quality, it may affect your ability to fall asleep later in the evening,' he said. 'Maintaining a consistent sleep schedule, where you wake up and go to bed at the same time every day, is really important for ensuring you have a good night of quality sleep.' What do sleep doctors do in the morning instead? We know what they don't do in the mornings. So, what do sleep doctors do? One thing that came up consistently was ensuring they were exposed to light early in the morning. 'One of the first things I do in the morning, usually within 30 minutes of waking, is exposing myself to natural sunlight by going outside or sitting by a window,' Rohrscheib said. 'Light during the day is very important for keeping our circadian rhythm well-regulated. Studies have shown that a lack of sunlight exposure can reduce the quality of your sleep, contribute to insomnia, and negatively impact mood.' Dasgupta also makes sure to get sun exposure first thing in the morning. 'Getting sunlight exposure first thing in the morning upon waking up can increase alertness and energy during the day, leading to improved sleep at night,' he said. Another big tip that came up? Exercise. 'Getting active quickly is a fantastic way to signal to your brain that the day has begun,' Winter said. 'The exercise does not have to be particularly intense. I start my day off by walking my dogs every day or walking with my wife to work.' Interestingly, another thing Winter always makes sure to do is make his bed. 'It's not only symbolically powerful, but it's also a great deterrent for individuals who might want to slip back into bed during the day and feel the napping might adversely affect their sleep the upcoming night,' he said. As far as we're concerned, the fact that sleep doctors don't say anything about giving up coffee is a big win. As long as we can have our coffee, we don't mind dragging ourselves out of bed before checking emails and scrolling through Instagram. This article originally appeared on HuffPost. Also in Goodful: Therapists Are Revealing The Moments That Made Them Break Their "No Judgment" Rule, And I'm Honestly Speechless Also in Goodful: 25 Eye-Opening Confessions From A Trauma Therapist That Changed The Way I Think About Mental Health Also in Goodful: Medical Professionals Are Sharing "Mundane" Things That Actually Make So Many People Sick
Yahoo
an hour ago
- Yahoo
Marijuana use dramatically increases risk of dying from heart attacks and stroke, large study finds
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being. Using marijuana doubles the risk of dying from heart disease, according to a new analysis of pooled medical data involving 200 million people mostly between the ages of 19 and 59. 'What was particularly striking was that the concerned patients hospitalized for these disorders were young (and thus, not likely to have their clinical features due to tobacco smoking) and with no history of cardiovascular disorder or cardiovascular risk factors,' said senior author Émilie Jouanjus, an associate professor of pharmacology at the University of Toulouse, France, in an email. Compared to nonusers, those who used cannabis also had a 29% higher risk for heart attacks and a 20% higher risk for stroke, according to the study published Tuesday in the journal Heart. 'This is one of the largest studies to date on the connection between marijuana and heart disease, and it raises serious questions about the assumption that cannabis imposes little cardiovascular risk,' said pediatrician Dr. Lynn Silver, a clinical professor of epidemiology and biostatistics at University of California, San Francisco. 'Getting this right is critically important because cardiovascular disease is the top cause of death both in the United States and globally,' said Silver, who is also senior adviser at the Public Health Institute, a nonprofit public health organization that analyzes marijuana policy and legalization. Silver is the coauthor of an editorial published with the paper that calls for change in how cannabis is viewed by health professionals, regulatory bodies and the public at large. 'Clinicians need to screen people for cannabis use and educate them about its harms, the same way we do for tobacco, because in some population groups it's being used more widely than tobacco,' she said. 'Our regulatory system, which has been almost entirely focused on creating legal infrastructure and licensing legal, for-profit (cannabis) businesses, needs to focus much more strongly on health warnings that educate people about the real risks.' The new systematic review and meta-analysis analyzed medical information from large, observational studies conducted in Australia, Egypt, Canada, France, Sweden and the US between 2016 and 2023. Those studies did not ask people how they used cannabis — such as via smoking, vaping, dabbing, edibles, tinctures or topicals. (Dabbing involves vaporizing concentrated cannabis and inhaling the vapor.) However, 'based on epidemiological data, it is likely that cannabis was smoked in the vast majority of cases,' Jouanjus said. Smoking tobacco is a well-known cause of heart disease — both the smoke and the chemicals in tobacco damage blood vessels and increase clotting, according to the US Centers for Disease Control and Prevention. Therefore, it is not surprising that smoking, vaping or dabbing cannabis could do the same, Silver said: 'Any of the many ways of inhaling cannabis are going to have risks to the user, and there's also secondhand smoke risks, which are similar to tobacco.' The notion that smoking cannabis is less harmful because it's 'natural' is just wrong, Dr. Beth Cohen, professor of medicine at the University of California, San Francisco, told CNN in a prior interview. 'When you burn something, whether it is tobacco or cannabis, it creates toxic compounds, carcinogens, and particulate matter that are harmful to health,' Cohen said in an email. However, edibles may also play a role in heart disease, according to a May 2025 study. People who consumed edibles laced with tetrahydrocannabinol, or THC, showed signs of early cardiovascular disease similar to tobacco smokers. 'We found that vascular function was reduced by 42% in marijuana smokers and by 56% in THC-edible users compared to nonusers,' Dr. Leila Mohammadi, an assistant researcher in cardiology at the University of California, San Francisco, told CNN in a prior interview. None of the studies included in the new meta-analysis asked users about the potency of THC in the products they consume. Even if they had, that information would be quickly outdated, Silver said. 'The cannabis market is a moving target. It is getting more potent every day,' she said. 'What's being sold to people today in California is 510 times stronger than what it was in the 1970s. Concentrates can be 99% pure THC. Vapes are over 80% THC. 'A variety of chemically extracted cannabinoids can be almost pure THC, and all of these just have very different effects on people than smoking a joint in the 1970s.' Higher potency weed is contributing to a host of problems, including an increase in addiction — a July 2022 study found consuming high-potency weed was linked to a fourfold increased risk of dependence. In the United States, about 3 in 10 people who use marijuana have cannabis use disorder, the medical term for marijuana addiction, according to the CDC. 'We know that more potent cannabis makes people more likely to become addicted,' Silver said. 'We know that more potent cannabis makes people more likely to develop psychosis, seeing and hearing things that aren't there, or schizophrenia. Habitual users may also suffer from uncontrollable vomiting.' The rise in potency is one reason that the current study may not have captured the full extent of the risk of marijuana for heart disease, Jouanjus said: 'We are afraid that the association might be even stronger than that reported.' While science continues to study the risk, experts say it's time to think twice about the potential harms of cannabis use — especially if heart disease is a concern. 'If I was a 60-year-old person who had some heart disease risk, I would be very cautious about using cannabis,' Silver said. 'I've seen older people who are using cannabis for pain or for sleep, some of whom have significant cardiovascular risk, or who have had strokes or had heart attacks or had angina, and they have no awareness that this may be putting them at greater risk.'
Yahoo
an hour ago
- Yahoo
AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine
Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial public offering, aiming to raise up to $423.5 million. The Irving, Texas-based firm, backed by investment giants Sixth Street and Neuberger Berman, has already conducted 6.5 million molecular tests across 849,000 patient cases, establishing partnerships with over 100 biopharmaceutical firms, including Moderna Inc (NASDAQ:MRNA) and AbbVie (NYSE:ABBV), according to its prospectus filed with the U.S. Securities and Exchange Commission. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – The $5.35 billion target—based on 23.5 million shares priced between $16 and $18 each—marks a notable shift from Caris' 2021 private valuation of $7.83 billion, Reuters reported, reflecting both market recalibration and the challenges of commercializing precision medicine. According to its filing, Caris generated $412.3 million in revenue in 2024—a 35% year-over-year increase—while posting a net loss of $257.1 million. In Q1 2025, the company reported $120.9 million in revenue and a narrowed net loss of $127 million, compared to $80.7 million in revenue and a $134.1 million loss during the same period in 2024, according to its filing—signaling improving margins and sustained top-line growth. At its proposed valuation, Caris would trade at approximately 13 times sales, a premium to peers like Guardant Health (NASDAQ: GH) and Tempus AI (NASDAQ: TEM), Reuters reported. Trending: Invest where it hurts — and help millions heal:. According to the company's website, Caris was founded in 2008 by entrepreneur David D. Halbert, who was inspired by his father's cancer battle to develop more effective, data-driven diagnostics. Today, the company operates from its North Texas headquarters and has offices in Phoenix, New York, Cambridge, Massachusetts, Tokyo, Japan, and Basel, Switzerland, serving both U.S. and international markets. Caris' proprietary AI platform, which integrates molecular science with machine learning, analyzes comprehensive genomic, transcriptomic, and proteomic data to guide cancer treatment. The company holds 27 issued patents along with over 170 applications pending worldwide, according to its website. Its flagship MI Cancer Seek test, cleared by the U.S. Food and Drug Administration in 2023, detects early-stage malignancies with what the company claims is unmatched accuracy, the company said at the time. Caris will trade on the Nasdaq under the symbol CAI The offering is led by BofA Securities, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and Citigroup Global Markets. Grand View Research projects a 22.5% CAGR in the AI cancer diagnostics market through 2030, highlighting strong growth potential in this Berman has indicated it may purchase up to $75 million worth of shares in the IPO—signaling insider confidence in the company's long-term potential, according to Reuters. Caris Life Sciences currently has one FDA-cleared diagnostic test, MI Cancer Seek, according to its filing. Caris' pipeline includes investigational tools like FOLFIRSTai, an AI-based test for predicting chemotherapy response in metastatic colorectal cancer. While clinically validated, it remains unapproved by the FDA, according to the SEC filing, and stricter regulations could delay its commercialization. Caris's proposed IPO is drawing attention as a potential marker for the viability of AI-driven healthcare, with Reuters noting the offering comes amid renewed interest in precision diagnostics. Read Next: Here's what Americans think you need to be considered wealthy. Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? MODERNA (MRNA): Free Stock Analysis Report This article AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.